This search looks for keywords in all of the website’s content. Search tips
Filter by
The European Sales and Use of Antimicrobials for Veterinary Medicine Working Group (EUSAvet) provides strategic guidance and recommendations to the European Medicines Agency (EMA) and its Committee for Veterinary Medicinal Products (CVMP). This guidance refers to the collection and analysis of data on sales volumes of veterinary antimicrobials and...
Veterinarians serve as the first line of defence against emerging diseases and play a crucial role in mitigating the development of antimicrobial resistance (AMR).
The European Medicines Agency (EMA) is a member of the International Coalition of Medicines Regulatory Authorities (ICMRA). ICMRA is a voluntary, executive-level entity of worldwide medicines regulatory authorities set up to provide strategic coordination, advocacy and leadership.
Countries that have decreased their consumption of antibiotics in both animals and humans have seen a reduction in antibiotic-resistant bacteria.
The European Medicines Agency (EMA) works closely with the European Food Safety Authority (EFSA) and the European Centre for Disease Prevention and Control (ECDC) to analyse the potential relationship between the consumption of antimicrobials by humans and animals and the occurrence of antimicrobial resistance.
EMA has just launched the new Antimicrobial Sales and Use (ASU) platform to support the collection of data by Member States on the sales and use of antimicrobials in animals.
European countries have substantially reduced sales of veterinary antibiotics.
The European Medicines Agency (EMA) is involved in monitoring and evaluating the risks of using antibiotics in animals. It has looked in particular at the risk of the development of antimicrobial resistance in animals and of the possible transmission of resistance to humans.
The European Surveillance of Veterinary Antimicrobial Consumption (ESVAC) project collected information from 2009 to 2023 on how antimicrobial medicines are used in animals across the European Union (EU). This type of information is essential to identifying possible risk factors that could lead to the development and spread of antimicrobial...
Combatting the threat of antimicrobial resistance, particularly resistance to antibiotics, is a high priority for the European Medicines Agency (EMA) and the European medicines regulatory network. In veterinary medicine, EMA is promoting prudent use of antimicrobials in animals, collecting data on the use of veterinary antimicrobials in the...